Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
COCP
#3809
Cocrystal Pharma, Inc. Common Stock
1.0
4
-2.80%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.80%
Monatliche Änderung
0.00%
6 month change
-31.58%
Jahresänderung
-40.23%
Vorheriger Schlusskurs
1.0
7
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
4
Volumen
7
Märkte
Aktien
Gesundheitswesen
COCP
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
10.17 M
10.17 M
10.17 M
10.26 M
13.78 M
—
Valuation ratios
Enterprise value
4.89 M
10.69 M
7.53 M
10.52 M
9.5 M
38.24 M
Price to earnings ratio
-0.97
-1.17
-0.91
-1.21
-1.34
-4.64
Price to sales ratio
-113.46
-126.08
-81.16
-76.18
-67.12
-350.54
Price to cash flow ratio
-1.06
-1.25
-0.97
-1.13
-1.33
-4.68
Price to book ratio
0.22
2.16
0.31
0.43
0.43
3.33
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.3
0.24
-0.22
0.24
0.2
0.46
Return on equity %
0.39
0.34
-0.32
0.39
0.27
0.68
Return on invested capital %
—
373.03
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
63.03 K
-1 374.47
78.03 K
8 432
11.61 K
96.7 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
61.74 K
-1 388.09
-76.7 K
8 220
11.38 K
-58.48 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.32
4.77
4.57
3.69
5.78
18.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
-0.02
0
0
0
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.12
0.31
-0.29
-0.21
-0.12
-0.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.28
0.97
0.68
0.47
0.7
2.82
Net current asset value per share
1.4
1.14
0.87
0.66
0.8
3.47
Tangible book value per share
1.25
0.94
0.72
0.52
0.7
2.88
Working capital per share
1.21
0.9
0.68
0.48
0.66
2.72
Book value per share
1.25
0.94
0.72
0.52
0.7
2.88
Nachrichten
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Insiderkauf bei Cocrystal Pharma: Großaktionär Phillip Frost stockt Anteile auf
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Cocrystal Pharma schließt Direktplatzierung über 4,7 Mio. US-Dollar ab
Cocrystal Pharma closes $4.7 million registered direct offering
Cocrystal Pharma beschafft 4,7 Millionen US-Dollar über registriertes Direktangebot
Cocrystal Pharma raises $4.7 million in registered direct offering
Cocrystal Pharma: Norovirus-Medikament CDI-988 geht in die nächste klinische Phase/n
Cocrystal’s norovirus drug CDI-988 advances to phase 1b study